United Health's most recent trend suggests a bearish bias. One trading opportunity on United Health is a Bear Call Spread using a strike $255.00 short call and a strike $260.00 long call offers a potential 27.55% return on risk over the next 10 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $255.00 by expiration. The full premium credit of $1.08 would be kept by the premium seller. The risk of $3.92 would be incurred if the stock rose above the $260.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for United Health is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for United Health is bearish.
The RSI indicator is at 27.01 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for United Health
5 Top Blue Chip Stocks to Buy Now
Sun, 04 Aug 2019 16:10:00 +0000
When looking for blue chip investment options for your portfolio, don't settle for less than the best of the best.
Scorecard: A year ago, Envision Healthcare was sold for $9.9 billion. Here's what's happened since.
Fri, 02 Aug 2019 19:40:00 +0000
Scorecard checks back on our headlines from a year ago. This is an update to the June 11, 2018, story "Envision Healthcare sold for $9.9 billion."
David Carlson Goes 2 for 2 in 2nd Quarter
Fri, 02 Aug 2019 17:56:40 +0000
Guru invests in Dutch semiconductor company and a major telecom company Continue reading…
Ensign Group's (ENSG) Q2 Earnings Beat Estimates, Rise Y/Y
Fri, 02 Aug 2019 15:31:03 +0000
Ensign Group's (ENSG) second-quarter earnings gain traction from improved revenues.
MEDNAX's (MD) Earnings Beat Estimates in Q2, Decrease Y/Y
Fri, 02 Aug 2019 15:26:03 +0000
Mednax's (MD) Q2 gains on revenue growth, partly offset by rise in expenses.
Related Posts
Also on Market Tamer…
Follow Us on Facebook